Looking for some bad pharma news? You've come to the right place. In this story, the Wall Street Journal reports on a gloomy forecast from Severin Schwan, CEO of Roche, who predicts that some drug makers will face bankruptcy or mergers due to a lack of "innovative medicines." He is quoted as saying, "Those who fail to bring sufficient innovation will be squeezed out of this market." In other news, Stephen Albainy-Jenei at Patent Baristas has a post reporting on findings from the European Commission indicating that pharmas have "engaged in delaying or blocking market entry of competing medicines." He adds, "The EU thinks that ... these [delaying] practices result in significant additional costs for health care -- and ultimately taxpayers and patients -- and reduce incentives to innovate."
It's a Tough Time to Be a Pharma
Dec 08, 2008